About Emerging Markets - China
Emerging Markets - China is the first and only syndicated report series focusing on high-growth emerging markets with comprehensive disease-specific analysis. With these reports, biopharmaceutical companies can accomplish the following:
-- More accurately assess their commercial opportunity for Western brands
in key pharmaceutical markets of China -- Beijing, Shanghai, Guangzhou
-- and in the high-growth second-tier markets of Tianjin, Wuhan,
Nanjing, Hangzhou, and Jinan.
-- Understand the physician treatment patterns and drivers of choice in
key first- and second-tier cities based on primary research.
-- Gain a clear perspective of the Chinese 5-year market forecast at the
drug level, broken out by urban and rural areas, and by sales from
multinational and Chinese-based companies.
About Decision Resources
Decision Resources, Inc., ( http://www.DecisionResources.com ) is a world leader in healthcare market research publications, advisory services, and consulting designed to help clients shape strategy, allocate resources, and master their chosen markets.
All company, brand, or product names contained in this document may be trademarks or registered trademarks of their respective holders.
Decision Resources, Inc.
|SOURCE Decision Resources|
Copyright©2007 PR Newswire.
All rights reserved